Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on: January 04,2024

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on:January 04,2024

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on: August 30,2025

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on:August 30,2025

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on: June 01,2024

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on:June 01,2024

CAR-T Therapy Under Scrutiny: The Emerging Risk of Secondary Malignant Tumors

CAR-T therapy has long been an effective treatment for hematological cancers such as leukemia and lymphoma. However, some patients have developed secondary malignant tumors after undergoing CAR-T ......

Updated on: May 29,2024

CAR-T Therapy Under Scrutiny: The Emerging Risk of Secondary Malignant Tumors

CAR-T therapy has long been an effective treatment for hematological cancers such as leukemia and lymphoma. However, some patients have developed secondary malignant tumors after undergoing CAR-T ......

Updated on:May 29,2024

Harms reporting is inconsistent across organ cancer guidelines

byAmerican College of PhysiciansCredit: CC0 Public DomainA review of 33 organ-specific cancer screening guidelines has found that the reporting of harms related to screening tests and procedures

Updated on: December 22,2023

Harms reporting is inconsistent across organ cancer guidelines

byAmerican College of PhysiciansCredit: CC0 Public DomainA review of 33 organ-specific cancer screening guidelines has found that the reporting of harms related to screening tests and procedures

Updated on:December 22,2023

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

byEuropean Society for Medical OncologyLead author Barbara Pistilli, a medical oncologist at Institut Gustave Roussy, Villejuif, France. Credit: European Society for Medical OncologyNearly one i

Updated on: December 18,2023

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy

byEuropean Society for Medical OncologyLead author Barbara Pistilli, a medical oncologist at Institut Gustave Roussy, Villejuif, France. Credit: European Society for Medical OncologyNearly one i

Updated on:December 18,2023

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on: December 25,2023

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on:December 25,2023

Natural compounds derived from soy and other plants found to reduce breast cancer recurrence and improve survival

JANUARY 10, 2024Natural compounds derived from soy and other plants found to reduce breast cancer recurrence and improve survivalbyJohns Hopkins University School of MedicineFlow diagram of the

Updated on: March 15,2024

Natural compounds derived from soy and other plants found to reduce breast cancer recurrence and improve survival

JANUARY 10, 2024Natural compounds derived from soy and other plants found to reduce breast cancer recurrence and improve survivalbyJohns Hopkins University School of MedicineFlow diagram of the

Updated on:March 15,2024

Melanoma misconception: Dark skin tones at risk, too

by Sonya GoinsCredit: Unsplash/CC0 Public DomainThe myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It's a dangerous misconception that

Updated on: January 10,2024

Melanoma misconception: Dark skin tones at risk, too

by Sonya GoinsCredit: Unsplash/CC0 Public DomainThe myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It's a dangerous misconception that

Updated on:January 10,2024

Looking at the environment around tumors could help predict how cancer spreads

byUniversity College LondonRepresentative images of high granulocyte infiltration in the tumor nest and stroma for LUAD (left) and LUSC (right). Credit:Cancer Discovery(2024). DOI: 1

Updated on: April 28,2024

Looking at the environment around tumors could help predict how cancer spreads

byUniversity College LondonRepresentative images of high granulocyte infiltration in the tumor nest and stroma for LUAD (left) and LUSC (right). Credit:Cancer Discovery(2024). DOI: 1

Updated on:April 28,2024

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Updated on: April 29,2025

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Updated on:April 29,2025

Early clinical trial data show gene therapy reversing sickle cell anemia

by Cincinnati Children's Hospital Medical CenterTechnicians work in the ISO-certified cleanroom laboratory at Cincinnati Children's, where gene-correction therapies are tested and produce

Updated on: April 20,2024

Early clinical trial data show gene therapy reversing sickle cell anemia

by Cincinnati Children's Hospital Medical CenterTechnicians work in the ISO-certified cleanroom laboratory at Cincinnati Children's, where gene-correction therapies are tested and produce

Updated on:April 20,2024